V Ketamine Promising for Severe Refractory Headache in Children

In a retrospective chart review, IV ketamine led to in a 50% reduction in pain at discharge, with “nearly two-thirds” of patients having no recurrence within 30 days, lead investigator Scott Rosenthal, from the University of Colorado Anschutz Medical Campus, Aurora, noted. Rosenthal reported the findings (Abstract S20.010) on April 15 at the American Academy of Neurology 2024 annual meeting.